Canadian HIV criminalisation laws increase violence against women living with HIV

A majority of women living with HIV in Canada report a history of verbal, physical, and/or sexual violence from partners, according to a study published in Women’s Health. And one fifth of the women in the study, especially Indigenous women and Black women, reported that Canada’s HIV non-disclosure laws had led to increased violence.

Canada has one of the highest number of HIV criminalisation cases globally. HIV status non-disclosure is considered a crime unless condoms are used and a person’s viral load is less than 1,500, regardless of whether HIV transmission occurred.

Non-disclosure is considered to invalidate informed consent, so it is most often prosecuted as a sexual assault or even an aggravated sexual assault which can lead to life imprisonment and/or lifelong branding as a sexual offender.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below